Yersinia outer proteins
Yersinia pestis evades immune responses in part by injecting into host immune cells several effector proteins called Yersinia outer proteins (Yops) that impair cellular function. This has been best characterized in the innate effector cells, but much less so for cells involved in adaptive immune responses. Dendritic cells (DC) sit at the crossroads between innate and adaptive immunity, and can function to initiate or inhibit adaptive immune responses. Although Y. pestis can target and inactivate DC, the mechanism responsible for this remains unclear. We have found that injection of Y. pestis YopJ into DC progenitors disrupts key signal transduction pathways and interferes with DC differentiation and subsequent function. YopJ injection prevents up-regulation of the NF-κB transcription factor Rel B and inhibits MAPK/ERK activation – both having key roles in DC differentiation. Furthermore, YopJ injection prevents costimulatory ligand up-regulation, LPS-induced cytokine expression, and yields differentiated DC with diminished capability to induce T cell proliferation and IFN-γ induction. By modulating DC function through YopJ-mediated disruption of signaling pathways during progenitor to DC differentiation, Yersinia may interfere with the adaptive responses necessary to clear the infection as well as establish a tolerant immune environment that leads to chronic infection/carrier state in the surviving host.
Yersinia pestis is a gram-negative bacterium and the etiological agent of plague 1. Despite being an extracellular bacterium, Y. pestis employs a rather remarkable system to target/suppress the host immune system through direct injection of several effector proteins, collectively called the Yersinia outer proteins (Yops), into the cytoplasm of immune cells 1–3. Secretion of Yops across the bacterial membranes and injection of Yops into the cytoplasm of eukaryotic cells is mediated by a plasmid pCD1-encoded type III secretion system (T3SS) 4. Injection of effector Yops (YopE, YopH, YopJ, YopM, YopT and YpkA) into the effector cells of the innate immune system (polymorphonuclear leukocytes and macrophages) by Y. pestis and other pathogenic yersiniae (Y. enterocolitica and Y. pseudotuberculosis) results in the disruption of the host cell cytoskeleton, inhibition of inflammatory responses and prevention of bacterial phagocytosis 4–9.
Although its modulation of innate immunity has been best characterized, Yersinia also target cells of the adaptive immune response. T cells mediate protection against Y. enterocolitica10, and immunity to plague is principally mediated by antibodies that require an intact CD4+ T helper response 11, 12. Conversely, yersiniae directly interfere with B and T cell activation 13 and disrupts the function of antigen-presenting cells (APC) 14. Of the professional APC, dendritic cells (DC) play the predominate role in activating and regulating T cell responses 15. Thus, disabling DC function may benefit the survival of a pathogen. Consistent with this, Marketon et al.3 have found that DC (and macrophages) are the early and predominant targets for Y. pestis Yop injection in vivo. Myeloid DC progenitors (e.g. monocytes, macrophages) in the blood or lymph nodes are also targets for the pathogen and serve as reservoirs of infection 3, 16. Other pathogenic Yersinia spp. (e.g. Y. enterocolitica) also can impair DC function and induce DC apoptosis (in mice) 14, 17, 18, and it has been recently shown that Y. pestis inhibits cellular migration in fully differentiated murine DC 19.
A more insidious effect of Yersinia infection on DC function is suggested by the following observations: (i) inhibition of the NF-κB (especially the NF-κB family member Rel B) and the MAPK (ERK) signaling pathways during progenitor to DC differentiation cripples the function of the resulting DC 20, 21, and in fact NF-κB inhibition yields regulatory DC 22, (ii) Yersinia effectively injects Yops into myeloid DC progenitors that are abundant at the site of infection (and the infected draining lymph nodes, bubos) and may be triggered to undergo DC differentiation by the inflammatory cytokine microenvironment, and (iii) YopJ has a ubiquitin-like cysteine protease and acetyltransferase activity that inhibits activation of MAP kinase kinases (MKKs) and NF-κB signaling in vitro and in macrophages 23, 24. Together these findings suggest that Yersinia may not only disable existing DC, but also cripple the function of new DC being produced to replace the existing DC. In this report we have examined whether YopJ of Y. pestis can disrupt key signaling pathways in DC progenitors, resulting in the differentiation into DC that have impaired immunostimulatory capability.
Effect of injection competent vs. incompetent strains of Y. pestis on DC differentiation
We have previously shown that the multipotent human myeloid leukemia cell line K562 can be induced to undergo differentiation to DC-like APC when stimulated with the phorbol ester PMA 25. K562 exhibit a less robust up-regulation of certain DC markers (MHC class I, II and CD83) compared to primary human DC precursors (monocytes, CD34+ hematopoietic stem cells), but develop equipotent ability to activate T cells. Because the same intracellular signaling pathways appear to be activated in K562 and primary precursors during DC differentiation, and because K562 are a homogenous population, this cell line is a readily accessible model to study YopJ's effects on DC signal transduction. We first examined the effect of YopJ on DC differentiation by infecting K562 with injection competent (Y. pestis KIM5–3001.48; YopB+YopJ+) and injection defective (Y. pestis KIM5–3001.49; YopB–YopJ+) poly-yop-deleted strains expressing a functional plasmid-expressed GSK epitope-tagged YopJ protein 26, 27. Both strains carry deletions in pCD1 genes encoding the six effector Yops; therefore, YopJ-GSK is the only effector Yop injected. YopB is an essential component of the T3SS injection machinery 28, 29, and thus the YopB– strains cannot inject YopJ-GSK into eukaryotic cells. We utilized the GSK-tag reporter system to identify injected YopJ 26, 27. The GSK tag is only phosphorylated within eukaryotic cells 30, 31, and can be detected using phospho GSK-specific antibodies. While both strains expressed the YopJ-GSK fusion protein (Fig. 1A, bottom panel), only the YopB+ strain was able to inject YopJ-GSK into the K562 cells as detected by the phospho-GSK tag (top panel).
We next examined if YopJ-GSK affected NF-κB signaling during DC differentiation. Induction of Rel B gene expression is a critical event in DC differentiation, and this up-regulation is itself mediated by NF-κB signaling 32–35. As shown in Fig. 1B, Rel B is strongly up-regulated by PMA-induced differentiation of K562. Undifferentiated K562 infected with the YopB–YopJ+ strain expressed a low level of Rel B that was also greatly increased by PMA. In contrast, injection of YopJ-GSK by the YopB+YopJ+ strain substantially inhibited Rel B up-regulation in differentiating K562. NF-κB signaling/Rel B upregulation have been implicated in up-regulating CD40 expression during DC differentiation 22, which correlates with the observation that PMA induced significant CD40 expression in uninfected K562 and YopB–YopJ+-infected K562, with much lower expression in the YopB+YopJ+-infected K562 (Fig. 1C). Infection alone in the absence of PMA did not up-regulate CD40 (not shown).
The functional hallmark of DC is their potent ability to activate T cells. In our system, undifferentiated K562 do not stimulate T cells, while PMA-differentiated K562 induce robust allo-T cell proliferation (Fig. 1D, left). Undifferentiated K562 infected with either Y. pestis strain also did not stimulate T cell proliferation, while PMA-differentiated cells derived from YopB–YopJ+-infected K562 induced allo-T cell proliferation to levels similar to uninfected K562-derived DC-like cells or the positive control (T cells alone stimulated PMA + ionomycin) (Fig. 1D, right). The decrease in T cell proliferation from the 1:10 to 1:2 APC–T cell ratio is due to media exhaustion in the rapidly proliferating cultures, which is not seen with less immunostimulatory DC-like cells. In contrast to the YopB–J+ infection, YopB+YopJ+ infected K562-DC-like cells were significantly impaired in their ability activate T cells. This latter result also demonstrates that PMA carryover from the differentiation cultures is not inducing significant T cell proliferation.
Effect of injection competent YopJ+vs. YopJ– strains
In the preceding studies the strains compared differed in expression of YopB, and not YopJ. It is, therefore, possible that the differences seen above are due to YopB and not YopJ, as YopB can also affect eukaryotic signal transduction 36. To assess this, we examined the effects of Y. pestis KIM5–3001.48 (YopB+YopJ–), a injection competent poly-yop deletion mutant either carrying (YopB+YopJ+) or not carrying (YopB+YopJ–) the pYopJ-GSK plasmid. The strains did not differ in their ability to induce K562 cell death immediately after infection (Table 1).
|Before infection (day 0)||After infection (day 0)||After infection (PMA day 5)|
|Uninfected||10||NA||4.3 ± 1.1|
|B+J+||15||12.5 ± 2.2||10 ± 0.9|
|B+J–||15||11.8 ± 1.4||6.7 ± 1.2|
The effect of YopJ-GSK on the downstream MAPK/ERK and NF-κB signaling induced by PMA differentiation is shown in Fig. 2A. Rapid signaling through the MAPK pathway (ERK 1 and 2 phosphorylation) is seen within 45 min, while up-regulation of Rel B expression (as an indicator of NF-κB signaling) is seen by 24 h (left). This signaling in YopB+YopJ–-infected K562 differentiated with PMA was similar to uninfected cells. In contrast, YopB+YopJ+-infected K562 had significantly reduced MAPK/ERK and NF-κB signaling (densitometry, right). Interestingly, injected YopJ-GSK was still detected 24 h post infection, suggesting that YopJ is not rapidly degraded. Rel B expression was also examined in undifferentiated K562 infected with the YopB+YopJ+ or YopB+YopJ– strains to determine if infection alone induced Rel B up-regulation (Fig. 2B), and neither strain could induce Rel B without the differentiation stimulus.
Consistent with the preceding experiments, CD40 up-regulation was unaffected by infection with the YopB+YopJ– strain, but inhibited by YopB+YopJ+ (Fig. 2C). Similarly, uninfected and YopB+YopJ–-infected K562 differentiated with PMA readily induced T cell proliferation, while YopB+YopJ+-infected K562 DC-like cells were significantly impaired (Fig. 2D). Across all experiments with different T cell donors, infection with the YopJ+ strain significantly (three- to sevenfold) inhibited the ability of the resulting DC-like cells to drive T cell proliferation.
YopJ-GSK effect on cytokine-induced primary monocyte to DC differentiation
While the homogeneity of the K562 model allows for a more precise delineation of the effects of YopJ-GSK on signal transduction and DC phenotype/function, transformed cell lines may not accurately reflect what happens in primary cells (for example, K562 DC-like cells express low levels of MHC class II and CD86). We therefore examined the effect of YopJ-GSK on in vitro human monocyte to DC differentiation 37. Since monocytes are known targets for Yersinia3, 38, we first characterized what Y. pestis infection did to the APC function of unmanipulated monocytes. While infection with either strain induced some cell death (Table 2, consistent with 9, 39), there was no difference between the strains, indicating that YopJ-GSK itself does not increase cell death in our experimental system.
|Before infection (day 0)||After infection (day 0)||After infection (day 1)|
|Uninfected||4.5||NA||3.1 ± 0.8|
|B+J+||7||4.8 ± 0.5||3.3 ± 0.5|
|B+J–||7||4.9 ± 0.7||3.2 ± 1.5|
YopB+YopJ+-infected monocytes induced less T cell proliferation compared with uninfected or YopB+YopJ–-infected monocytes (Fig. 3A), suggesting that YopJ-GSK interferes with the APC function even prior to differentiation. Comparatively, however, monocyte activation of T cells is much less potent than that by DC, allowing examination of the effect of YopJ-GSK on the acquisition of enhanced immunogenicity during DC differentiation.
High levels of LPS can block the initiation of DC differentiation in monocytes 40, 41. To bypass this potentially confounding variable, monocytes were first induced to differentiate with GM-CSF + IL-4, and infection carried out shortly afterwards (Fig. 3B, top). Similar to that described above, Yersinia infection of monocytes decreased the yield of differentiated DC (vs. uninfected monocytes) but there was little difference between the two strains (Table 3), indicating cell death is not a major contributor to the differences seen below.
|Before infection (day 0)||After infection (day 0)||After infection (GM/4/TNF day 7)|
|GM/4/TNF||2||NA||1.2 ± 0.25|
|B+J+ GM/4/TNF||3||1.5 ± 0.3||0.5 ± 0.3|
|B+J– GM/4/TNF||3||1.4 ± 0.4||0.4 ± 0.2|
|Parent GM/4/TNF||3||1.0 ± 0.5||0.6 ± 0.1|
|ΔJ GM/4/TNF||3||0.75 ± 0.3||0.5 ± 0.2|
The extended dendrite morphology of DC plays an essential role in their ability to activate T cells 42. Both uninfected and YopB+YopJ–-infected monocytes differentiate into adherent cells with long dendrites (Fig. 3B, lower), while YopB+YopJ+-infected monocytes remained round cells.
In addition to CD40, DC differentiation is characterized by up-regulation of MHC class I and class II, CD80, CD86 and CD83 expression, with loss of the monocyte marker CD14 (Fig. 3C). We have found that, while infection with YopJ+ or J– strains equivalently down-regulated MHC class I and II expression compared to mock-infected monocyte-derived DC (moDC) (which would not be consistent with a differential effect on DC maturation/activation), the YopJ+-infected moDC had markedly lower expression of the costimulatory ligands CD40, CD80 and CD86. There is a small subpopulation of cells that maintain higher levels of costimulatory ligand expression for unclear reasons – one possibility is that they were injected with less YopJ. The monocyte/macrophage marker CD14 is lost in all the conditions, suggesting that YopJ was not completely blocking differentiation. To assess the extent that LPS plays in the phenotypic changes seen, moDC were generated under the same cytokine conditions as above, but treated on day 3 with LPS alone (5 μg/mL per h) and then washed out – to mimic the conditions of infection with the Yersinia strains. In contrast to infection with the YopJ+ strains, LPS exposure alone resulted in a more mature/activated phenotype compared to cytokine alone, as indicated by higher expression of MHC class I, MHC class II, CD80, CD86 and CD83 (Fig. 3D).
We next examined if the phenotypic differences seen above were simply reflective of differences in DC activation/maturity, or whether they reflected a more fixed change set during differentiation. It has been well established that bacterial products potently drive DC maturation/activation (via the TLR), resulting in induction of DC cytokine/chemokine expression that subsequently plays a central role in activation of specific T cell responses. To assess this, DC differentiated from uninfected, YopB+YopJ–- or YopB+YopJ+-infected monocytes were treated with LPS and assayed for induction of IP-10, RANTES, IL-12p40, TGF-β and IL-10 by quantitative real-time PCR. As seen in Fig. 3D, infection with the YopJ– strain moderately inhibited LPS-mediated induction of IP-10, RANTES and IL-12p40 (and to a lesser extent IL-10) expression compared to the uninfected DC, and up-regulated IFN-β expression. However, DC differentiated from YopB+YopJ+-infected monocytes are nearly completely unresponsive to LPS stimulation as measured by cytokine induction. These results indicate that YopJ's effects during DC differentiation do not simply result in less mature (but still responsive) DC, but generate DC that are no longer responsive to TLR 4-mediated activation.
Induction of T cell responses
Inhibition of costimulatory ligand and cytokine expression predicts that the DC differentiated from YopB+YopJ+-infected monocytes will be less immunostimulatory. Consistent with this, DC differentiated from uninfected and YopB+YopJ–-infected monocytes elicited significantly greater T cell proliferation than moDC derived from YopB+YopJ+-infected monocytes (Fig. 4A). To examine whether a longer period of differentiation would diminish the negative effects of YopJ-GSK (suggesting a direct effect of residual YopJ-GSK protein from the original infection), monocytes were differentiated for 2 additional days (Fig. 4A right). However, the differences between the two strains were even more pronounced, consistent with the likelihood that YopJ-GSK is indirectly modulating DC function by affecting differentiation.
In addition to proliferation, up-regulation of cytokine production is a hallmark of T cell activation and is significantly influenced by the interacting DC. Recent studies have demonstrated an important role for IFN-γ in protective immunity against pulmonary Y. pestis infection 43. As seen in Fig. 4B, all three infection conditions (mock, YopB+YopJ–, YopB+YopJ+) yielded DC that elicited relatively similar frequencies of IL-4-expressing T cells (somewhat more for the J– strains and less for the J+ strains). In contrast, the marked increase in the percentage of IFN-γ-positive T cells elicited by the YopJ– DC (46%) is completely absent with YopJ+ DC (3.5%). This may be the result of the loss of IL-12 expression by YopJ+-infected DC (Fig. 3E), as DC production of IL-12 is an important factor in driving differentiation of IFN-γ-expressing Th1 T cells.
Infection with wild-type vs. ΔJ Y. pestis
As the preceding strains lack the other five effector Yops, it is possible that the effect of YopJ-GSK would be different if all the Yops were present. We therefore compared monocyte infection with the wild-type parental Y. pestis strain (expressing all six effector Yops) vs. a yopJ deletion mutant (ΔJ) expressing the other five Yops. An additional aspect of these studies is that YopJ is the native protein produced at normal amounts and without a GSK tag. As seen previously, there was no difference in cell death induced by either strain (Fig. 5A and Table 3). Interestingly, while DC differentiated from ΔJ-infected monocytes had a similar surface antigen phenotype to those from uninfected monocytes, WT-infected monocytes gave rise to a distinct subpopulation of cells that have decreased CD40, CD80 and CD86 expression (Fig. 5B), and to a lesser extent MHC class I, CD86 and CD83. This is similar to the staining pattern seen for the YopB+J+-infected monocytes (Fig. 3C), although the “high” staining DC subpopulation is larger when the parental WT strain is used. The reasons for these distinct subpopulations and the difference between the YopB+J+ and WT strains are unclear – possible explanations include the amount of YopJ injected (which may be less in the WT vs. YopB+J+ strains) and the effect of the other Yops injected by the parental strain that are not injected by the YopB+J+ strains. Also, similar to that seen with YopB+J+vs. YopB+J– strains, the allostimulatory ability of moDC from WT-infected monocytes was impaired compared to moDC differentiated from uninfected or ΔJ-infected monocytes (Fig. 5C).
Immune evasion by bacterial pathogens plays an important role in acute infection, and likely is even more important in chronic persistent infections. Although Y. pestis is characteristically an acute lethal infection in humans, it also causes a more persistent infection in more resistant hosts, maintaining its presence between the more dramatic outbreaks in susceptible populations 44. Other pathogenic Yersinia (Y. enterocolitica, Y. pseudotuberculosis) can clearly cause chronic disease in humans. How Yersinia avoids sterilizing immunity is poorly characterized; however, these three Yersinia species encode Yops with similar properties that play a critical role in evading components of the initial innate immune response 45–48, and are well positioned to impair the adaptive immune response necessary to clear the infection. Of these, YopJ (YopP in Y. enterocolitica) is a ubiquitin-like cysteine protease with promiscuous deubiquitinating 49 and acetyltransferase activity 24. This is not an essential virulence factor, but inhibits inflammatory responses and induces apoptosis in macrophages 9, 39, 50via inhibition of multiple signaling pathways (including MAPK and NF-κB) 23, 51. Although best characterized in the effector cells of the innate immune system (macrophages, monocytes), it has become evident that Yersinia can also inject Yops into professional APC like DC 3, potentially altering both the adaptive cellular and humoral immune responses that DC play an essential role in initiating. While less is known about YopJ's effect on DC, YopP in Y. enterocolitica infection of fully differentiated DC has been implicated in mediating apoptosis (in murine DC), suppressing cytokine production, antigen presentation and immunostimulatory capacity 14, 17, 18. In Y. pestis, YopJ appears to have less of a negative effect on the survival and immune function of differentiated murine DC, but rather has a marked effect on DC migration 19.
Our findings suggest that YopJ can also inhibit DC immunogenicity upstream of the mature DC, namely by disrupting signaling pathways during progenitor to DC differentiation. Accumulating evidence suggests that there are subsets of DC with defined function (not unlike T cells) that include regulation and inhibition of T cell responses (either directly or through generation of regulatory immune cells). How these regulatory DC subsets arise in vivo is not well defined , but we and others have found that pharmacological (or gene knockout) inhibition of the MAPK/ERK pathway during DC differentiation inhibits T cell stimulatory capability, while blocking NF-κB signaling (in particular Rel B) suppresses CD40 plus other costimulatory ligand expression, and results in DC that are tolerogenic (Lindner et al., manuscript submitted, 20–22, 52) or generate regulatory T cells 22. Our current findings suggest that a bacterial effector protein, YopJ, can also do this. We postulate that YopJ-GSK blocks NF-κB and MAPK signaling triggered by DC-differentiating agents, and results in disruption of the development of characteristic dendrite morphology, decreased costimulatory ligand expression (in particular CD40), loss of LPS responsiveness as measured by cytokine induction, and diminished capability to induce allo-T cell proliferation and IFN-γ production. The finding that infection with YopJ+ strains yields DC that are unresponsive to LPS (at least as measured by cytokine induction) indicates that YopJ is not simply generating immature but responsive DC, but a cell that is more functionally fixed. While an effect on TLR4-mediated responses by Yersinia virulence factors has not been reported, Yersinia V-antigen has been found to modulate TLR2 responses in macrophages to induce immunosuppressive IL-10 secretion 53. Although it is possible that YopJ is mediating these effects through pathways other than NF-κB and MAPK, many of our current findings are consistent with the previous studies using pharmacological inhibitors or gene knockout.
In contrast to these effects, we did not find an obvious role for YopJ in Yersinia-mediated cell death in our experimental system as has been reported for macrophages and murine DC. An important caveat is that our studies were not designed to rigorously characterize YopJ-mediated apoptosis. Interestingly, however, it has been recently suggested that YopJ-mediated killing of DC is a much less prominent feature of Y. pestis than seen for Y. enterocolitica19 or Y. pseudotuberculosis9.
The fact that YopJ-GSK is still present at significant levels 24 h after a 1-h infection suggests that YopJ is very stable within the eukaryotic cell. Previous studies have shown that the activities of injected bacterial effector proteins can be temporally regulated within the host cell by differential protein degradation 54. For example, the Salmonella enterica GEF SopE, which activates Rho-GTPase family members required for bacterial entry, has an extremely short half-life (t1/2 <30 min), whereas, SptP, an injected effector with GAP activity has a relatively long half-life (t1/2 >1 h), which allows this effector to reverse the cellular changes initiated by SopE following bacterial entry. In a similar manner, YopJ may be designed to function after the more cytotoxic anti-phagocytic Yops. Thus, injected YopE functions immediately to block bacterial phagocytosis and, if enough is injected, may kill the cell; however, if an injected monocyte/DC escapes YopE-mediated cell death (and migrates away from the site of active infection), YopJ may persist and function to prevent DC function and differentiation or lead to the generation of tolerance.
Our study contrasts with those of Saikh et al.55, who found that Y. pestis infection of human monocytes facilitates their differentiation to DC. This difference may be due to the different Yersinia strains used. We have used Pla+ strains, whereas Saikh et al.56 used Pla– strains. The Pla protease appears to be an essential virulence factor, and it is possible that the less virulent Pla– strains allow for better monocyte survival and activation/differentiation. Also, Pla functions in eukaryotic cell attachment, and thus may be required for efficient Yop injection. Thus, the Yop inhibitory effects on monocytes may be lessened in Pla– strains.
Despite the importance of T lymphocytes in protection against Yersinia spp., it has been shown that this response does not always protect the host infected with Y. pseudotuberculosis or Y. enterocolitica against persistent infections 57–60. These findings and our study suggests that Yersinia may cripple DC function to durably inactivate these responses. Thus, YopJ may not only participate in overcoming innate immunity in the acute setting, but may also modulate the immunological environment through its effects on DC to generate a setting conducive for chronic infections/carrier states.
Materials and methods
Cell culture and bacterial strains
K562 were obtained from American Type Culture Collection (Manassas, VA) and cultured as previously described 25 with 20 μg/mL chloramphenicol (Sigma-Aldrich, St. Louis, MO). DC differentiation was induced by 5-day culture with PMA as previously described 25.
PBMC were obtained from healthy donors, and monocytes isolated as previously described 37 or by plastic adherence followed by immunomagnetic-negative selection of CD3+ cell (Miltenyi Biotec). Typically, the monocytes purity ranged from 40% to 60%. For the experiments examining monocyte/DC surface phenotype and cytokine expression, monocytes were immunomagnetically purified by positive selection using CD14 microbeads (Miltenyi-Biotec), yielding monocyte purities >85%. Phenotypic and functional analysis of undifferentiated monocytes were done with fresh monocytes (within 24 h of isolation). To generate DC, monocytes were cultured with GM-CSF (1000 U/mL) and IL-4 (1000 U/mL) for 7 days, with TNF-α (10 ng/mL) added for the last day. Cell counts/viability were assessed by trypan blue.
Bacterial strains: Y. pestis KIM5 (parent) and derivatives of this strain used in this study are Pgm–61. Y. pestis KIM5–3173 is YopJ– (ΔJ) due to a bacteriophage Mu dI1734 insertion in yopJ of pCD1 62. The secretion- and injection-competent poly-yop deletion mutant Y. pestis KIM5–3001.48 (sycE yopE::km yopJ yopT yopM yopH ypkA lcrQ) and the injection-defective poly-yop deletion mutant KIM5–3001.49 (sycE yopE::km yopJ yopT yopM yopH ypkA lcrQ yopB) have been previously described 26. Plasmids pYopJ-GSK encodes full-length YopJ carrying a phosphorylatable C-terminal 13 residue GSK-tag that can be detected by phospho-specific anti-GSK antibodies (Cell Signaling, Beverly, MA). Y. pestis cultures were grown overnight at 27°C in heart infusion broth (HIB) and 100 μg/mL (ampicillin or streptomycin) or 25 μg/mL kanamycin. Overnight cultures were supplemented with 2.5 mM CaCl2, and grown at 27°C for 1 h, and 37°C for 2 h in the presence of 0.5% arabinose to induce YopJ-GSK expression. Bacteria were harvested by centrifugation and resuspended in IMDM containing 0.2% arabinose (no antibiotics) for infection experiments.
Infection of K562 and monocytes
Cells (5 × 106/mL) were serum starved for 30 min, and infected at an MOI of 30 (K562) or 10 (monocytes) at 37°C for 1 h. After infection cells were either lysed immediately or treated with 2 μg/mL gentamicin sulfate (BioWhittaker, Walkersville, ME) for 1 hour at 37°C to kill extracellular and intracellular bacteria, then used further for differentiation. Cells were placed back into media containing penicillin/streptomycin and chloramphenicol, and there was no bacterial outgrowth contamination over the next 10 days of cell culture.
Cells were stained as previously reported 63 using the following mAb: MHC class I and class II (VMRD Inc., Pullman, WA), CD14, CD80, CD86 (BD Pharmingen, San Diego, CA), CD40 and CD83 (both from Immunotech, Westbrook, ME). Appropriate isotype-matched Ab were used as controls and 10 000 live cells were analyzed on a Coulter XL flow cytometer (Coulter, Hialeah, FL). Staining with 2 μg/mL propidium iodine (PI) (Molecular Probes), and 1 μL/test Annexin-V (Biovision, Freiburg, Germany) was used for cell viability. For intracellular cytokine staining, purified allogeneic T cells were cocultured with the indicated DC for 3 days at a DC:T cell ratio of 1:10. Golgi Stop (BD PharMingen) was added for the last 5 h of culture. Cells were harvested, washed, stained with anti-CD3 FITC (BD Pharmingen, San Diego, CA) fixed and permeabilized, using Cytofix/Cytoperm kit (BD PharMingen) according to the manufacturer's instructions. Cells were then stained with 0.5 μg/test anti-IFN-γ-PE or anti-IL-4-PE and analyzed using CellQuest software (Becton Dickinson).
T cell proliferation assays
The DC generated were γ-irradiated (12 000 R 60Co for K562, 2000 R 60Co for monocytes) and cocultured with 1 × 105 cells/well purified allogeneic T cells. [Methyl-3H]thymidine (1 μCi/well) was added for the final 18 h of culture, and incorporation measured using the Beta Plate scintillation counting system (Wallac Inc., Gaithersburg, MD). All conditions were performed in triplicates, and data are represented as the mean counts of stimulators plus T cells minus counts of stimulators alone ± 1 SD.
Western blot for Rel B, phospho-ERK1/2, GSKβ, phospho-GSKβ, and actin were performed as previously described 63 using antibodies against Rel B (c-19) (Santa Cruz Biotechnology, Santa Cruz, CA), phospho-ERK1/2 (Cell Signaling), phospho-GSKβ (Cell Signaling) or β-actin (Sigma-Aldrich) (all at 1:500).
LPS-induced DC cytokine quantitation
DC were differentiated from purified monocytes as above, and then treated with LPS (5 μg/mL, InVivogen, San Diego, CA) for 6 h, or left untreated. RNA was isolated using RNeasy Mini Kits (Qiagen), cDNA was synthesized using a mix of oligo dT, random hexamer (Ambion) and SuperScript RT-III reverse transcriptase (Invitrogen Corp.) following manufacturer's protocol. Quantitative real-time PCR was performed on an iCycler (Bio-Rad Laboratories Inc.) using the following set of primers, designed to span introns: IP-10 forward: AGTGGCATTCAAGGAGTACCTC, reverse: GGACAAAATTGGCTTGCAGG; RANTES forward: ATCTGCCTCCCCATATTCCT, reverse: GTGACAAAGACGACTGCTGG; IL-12 p40 forward: GAGTACCCTGACACCTGGAGTAC, reverse: GCTGAGGTCTTGTCCGTGAAG; IFN-β forward: AGTGTCTCCTCCAAATTGCTCTCC, reverse: CCACAGGAGCTTCTGACACTGAAA; IL-10 forward: GGAGAACCTGAAGACCCTCA, reverse: GCCTTTCTCTTGGAGCTTAT; and GAPDH forward 5′-CGGAGTCAACGGATTTGGTCGTA-3′, reverse 5′-AGCCTTCATGGTGGTGAAGAC-3′. In each assay, the mRNA under study was normalized to an internal house-keeping gene (GAPDH) and expressed as fold induction. PCR reactions were run in triplicates of 30-µL reactions that contained Quanti-Tect Probe PCR Master Mix (QIAGEN), 4 pmol of each forward and reverse primer, and cDNA. Aliquots of first-strand cDNA were amplified using the QuantiTect SYBR Green PCR Kit (QIAGEN) under the following conditions: initial denaturation for 15 min at 94°C followed by 40 cycles consisting of 15 s at 94°C, 30 s at 60°C and 30 s at 72°C. Cycle numbers were obtained in the log-linear phase of the reaction and plotted against a standard curve generated for each set of primers. Results were analyzed in the linear part of the reactions using iCycler analysis software. The melting curve for each primer pair was used to monitor the purity of each quantified amplicon.
Statistical analysis was done using Student's unpaired t-test.
This work was supported by PHS/NIH grants CA85208, CA95829 and AI 39575.